Pantoprazole Tchaikapharma (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazole Tchaikapharma, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults. GNH USA supplies Pantoprazole Tchaikapharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoprazole Tchaikapharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): improves symptoms and promotes healing of the oesophageal lining. - Erosive oesophagitis: heals erosions and reduces further damage. - Peptic ulcer disease (duodenal and gastric ulcers): accelerates healing and prevents recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid production. - Maintenance therapy after ulcer healing: helps maintain a low‑acid environment to prevent relapse. - Prevention of NSA‑I‑‑  ​  ​  ​  ​  ​  ​  ​  ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​​

Pantoprazole is generally well‑tolerated, but adverse reactions can occur.

Common Side Effects: - Headache  - Diarrhea  - Nausea  - Abdominal pain  - Flat‑flat  - 

Serious or Rare      g    

g   g  t  g \

Pantopid    

      t   t  d \